MatOrtho Introduces Revolutionary All-Ceramic Hip Resurfacing System ReCerf® Approved in Australia

MatOrtho, a leading player in orthopedic innovations based in the UK, has made headlines with its recent announcement regarding the ReCerf® Hip Resurfacing Arthroplasty. This groundbreaking product is now recognized as the world’s first all-ceramic hip resurfacing system to receive regulatory approval. The Therapeutics Goods Administration (TGA) of Australia has officially granted its approval, which is seen as a significant milestone not only for MatOrtho but for the broader field of orthopedic surgery. Oriol Millet-López, the interim CEO of MatOrtho, described this achievement as monumental. He expressed that the ReCerf system represents years of dedication aimed at enhancing patient outcomes. The TGA's endorsement emphasizes the early performance results of ReCerf and its potential global impact on hip replacement procedures.

The ReCerf system has already achieved remarkable results since its introduction in September 2018, with over 1,200 patients benefiting from the device. Notably, the need for revision surgeries remains significantly lower than what is typically expected with conventional hip replacements. The Australian Orthopaedic Association National Joint Replacement Registry reported that ReCerf boasts a mere 0.3% revision rate within three years, underscoring its effectiveness. Both men and women, including young athletes, have resumed their active lifestyles without restrictions, further highlighting the system's success.

This breakthrough in TGA approval also paves the way for potential future advancements in hip resurfacing technologies. MatOrtho is actively collaborating with the Prosthesis Listing Advisory Committee in Australia to secure ReCerf's inclusion on the upcoming prosthesis list. The company is also engaging in the regulatory approval process in other key markets to extend the reach of its innovative ceramic-on-ceramic hip resurfacing solution.

Mike Tuke, the founder of MatOrtho, elaborated on the advantages of the fully ceramic 'delta' composition of the ReCerf system. This formulation eliminates concerns associated with metal implants, presenting a safe and effective alternative for patients. It allows for the preservation of a larger portion of the native hip joint, which could potentially reduce the necessity for traditional total hip replacements. Surgeons specializing in hip resurfacing can confidently opt for ReCerf, knowing it comes from a company that has significantly influenced the landscape of modern hip resurfacing.

Looking forward, the development of the ReCerf system is the result of over a decade of research and development by MatOrtho. This commitment combines clinical expertise with advanced materials to ensure the best possible long-term outcomes for patients. The approval of ReCerf is indeed a watershed moment in the orthopedic industry, prioritizing patient care and innovation.

For additional details regarding the ReCerf hip resurfacing system and MatOrtho's pursuit of orthopedic innovation, visit www.recerf.com.
For media inquiries, Dr. Michael Watson is available at MatOrtho, reachable via phone at 01372 224200 or email at [email protected]

About MatOrtho


MatOrtho stands at the forefront of orthopedic innovation, dedicated to advancing hip and knee replacement technologies that enhance patient outcomes and set new standards in the industry. With a focus on clinical excellence and patient-centric care, MatOrtho continues to reshape the future of orthopedic solutions across the globe.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.